Share this post on:

Product Name :
RMC-9805

Search keywords :
RMC-9805

drugId :
null

Target Vo:
V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog

Target Vo Short Name :
KRAS

Moa_Name:
V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Revolution Medicines Inc

Active Company_Name :
Revolution Medicines Inc

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BTK Antibody (YA816)
Phospho-4E BP1 (Thr46) Antibody
TREM2 Antibody: TREM2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to TREM2. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related